Brigitte Dréno
Centre National de la Recherche Scientifique(FR)Inserm(FR)Nantes Université(FR)
Publications by Year
Research Areas
Acne and Rosacea Treatments and Effects, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research
Most-Cited Works
- → Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma(2015)8,055 cited
- → Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation(2011)7,653 cited
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited
- → Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma(2014)2,015 cited
- → Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group(2012)1,342 cited
- → Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma(2000)1,264 cited